Forecasting

Revolutionising Gene Therapy with Strategic Conjoint Insights

Commercial

Challenge:

Gene therapy in haemophilia, 2nd/3rd entry with superior profile

Positioning hurdles due to previous therapies

A need to identify opportunities for a novel later-entry gene therapy within current market dynamics

solution

1.

Qualitative market landscaping and TPP Assessment

2.

Conjoint analysis with integrated order of entry assessment

3.

Co-creation workshop with marketing and forecasting teams

Delivered

1.

Gold standard conjoint simulator

2.

Integrated uptake curves and order of entry considerations

3.

Forecast simulator training and immersion with various ‘what if’ scenarios

Result

Empowered team to maximise potential of their gene therapy with a comprehensive tool for forecasting and strategic decision making.